TY - JOUR
T1 - Outcomes after laparoscopic cholecystectomy in patients older than 80 years
T2 - two-years follow-up
AU - Ramírez-Giraldo, Camilo
AU - Venegas-Sanabria, Luis Carlos
AU - Rojas-López, Susana
AU - Avendaño-Morales, Violeta
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/3/12
Y1 - 2024/3/12
N2 - Background: The laparoscopic cholecystectomy is the treatment of choice for patients with benign biliary disease. It is necessary to evaluate survival after laparoscopic cholecystectomy in patients over 80 years old to determine whether the long-term mortality rate is higher than the reported recurrence rate. If so, this age group could benefit from a more conservative approach, such as antibiotic treatment or cholecystostomy. Therefore, the aim of this study was to evaluate the factors associated with 2 years survival after laparoscopic cholecystectomy in patients over 80 years old. Methods: We conducted a retrospective observational cohort study. We included all patients over 80 years old who underwent laparoscopic cholecystectomy. Survival analysis was conducted using the Kaplan‒Meier method. Cox regression analysis was implemented to determine potential factors associated with mortality at 24 months. Results: A total of 144 patients were included in the study, of whom 37 (25.69%) died at the two-year follow-up. Survival curves were compared for different ASA groups, showing a higher proportion of survivors at two years among patients classified as ASA 1–2 at 87.50% compared to ASA 3–4 at 63.75% (p = 0.001). An ASA score of 3–4 was identified as a statistically significant factor associated with mortality, indicating a higher risk (HR: 2.71, CI95%:1.20–6.14). Conclusions: ASA 3–4 patients may benefit from conservative management due to their higher risk of mortality at 2 years and a lower probability of disease recurrence.
AB - Background: The laparoscopic cholecystectomy is the treatment of choice for patients with benign biliary disease. It is necessary to evaluate survival after laparoscopic cholecystectomy in patients over 80 years old to determine whether the long-term mortality rate is higher than the reported recurrence rate. If so, this age group could benefit from a more conservative approach, such as antibiotic treatment or cholecystostomy. Therefore, the aim of this study was to evaluate the factors associated with 2 years survival after laparoscopic cholecystectomy in patients over 80 years old. Methods: We conducted a retrospective observational cohort study. We included all patients over 80 years old who underwent laparoscopic cholecystectomy. Survival analysis was conducted using the Kaplan‒Meier method. Cox regression analysis was implemented to determine potential factors associated with mortality at 24 months. Results: A total of 144 patients were included in the study, of whom 37 (25.69%) died at the two-year follow-up. Survival curves were compared for different ASA groups, showing a higher proportion of survivors at two years among patients classified as ASA 1–2 at 87.50% compared to ASA 3–4 at 63.75% (p = 0.001). An ASA score of 3–4 was identified as a statistically significant factor associated with mortality, indicating a higher risk (HR: 2.71, CI95%:1.20–6.14). Conclusions: ASA 3–4 patients may benefit from conservative management due to their higher risk of mortality at 2 years and a lower probability of disease recurrence.
KW - Cholecystectomy
KW - Cholecystitis
KW - Elderly
KW - Surgery
KW - Cholecystectomy, Laparoscopic/methods
KW - Follow-Up Studies
KW - Humans
KW - Treatment Outcome
KW - Cholecystostomy/methods
KW - Cholecystitis, Acute/surgery
KW - Aged, 80 and over
KW - Retrospective Studies
KW - Gallbladder Diseases/surgery
UR - http://www.scopus.com/inward/record.url?scp=85187505296&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/6fea76d1-3c95-37ce-a922-72a706bf9e47/
U2 - 10.1186/s12893-024-02383-6
DO - 10.1186/s12893-024-02383-6
M3 - Artículo
C2 - 38475792
AN - SCOPUS:85187505296
SN - 1471-2482
VL - 24
SP - 87
JO - BMC Surgery
JF - BMC Surgery
IS - 1
M1 - 87
ER -